melanotan 2 protocol (10mg) – Nordsci Melanotan II – 10mg –
Description
Association of amino acid variations in the NS5A and E2-PePHD region of hepatitis C virus 1b with hepatocellular carcinoma

Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, et al

Androgen receptor in prostate cancer

ID: 61: ECHOCARDIOGRAPHIC EVALUATION IN TRANSFUSION-DEPENDENT THALASSEMIA BEFORE ATRIAL FIBRILLATION: THE FATHAL STUDY Di Stefano Valeria 1 , Gianesin Barbara 2 , Bertini Matteo 3 , Pisaniello Marco 4 , Culcasi Martina 5 , Denotti Anna Rita 6 , Giuditta Marianna 1 , Longo Filomena 7 , Manca Maria Regina 8 , Orecchia Valeria 6 , Origa Raffaella 6 , Motta Irene 1 1 Unit of Medicine and Metabolic Disease, Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico - Milan Italy, 2 Fondazione For Anemia - Genoa Italy, 3 Cardiology Unit, Ferrara University Hospital - Cona (FE) Italy, 4 Departmen of Cardio-Thoracic-Vascular Diseases, Foundation IRCCS C Granda Maggiore Hospital - Milan Italy, 5 Day Hospital Thalassemia and Hemoglobinopathies, Ferrara University Hospital- Cona Italy, 6 Centro Microcitemie e Anemie Rare, Pediatrico Microcitemico A
